Drug
Odm 204
Odm 204: highest development phase Phase 1/2, developed by Orion Corporation. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Orion Corporation
Trials
| Drug | Phase | Indication |
|---|---|---|
| ODM-204 NCT02344017 | Phase 1/2 | Prostate Cancer |
Latest
No recent events.
Follow Odm 204 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.